Clinicopathologic and Prognostic Implications of HOXA Gene and Its Associated Long-noncoding RNAs Expression in Non-small Cell Carcinoma: A Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2024 Aug 9

PMID 39121297

Authors

Yanhui Yang

JinYang Huang

Qi Wang

Ji Li

Lei Yu

Xiaoyang Xie

Affiliations

Soon will be listed here.

Abstract

Background: We conducted an investigation into the correlation between HOXA and associated long-noncoding RNAs, along with their clinicopathologic and prognostic features in non-small cell lung cancer (NSCLC).

Methods: A comprehensive search across multiple electronic databases, including PubMed and the Web of Science, was conducted to identify relevant studies. The association between HOXA, clinicopathologic parameters, and prognosis was assessed using relative risk (RR) and hazard ratio (HR) with a 95% confidence interval (CI). Data compilation was performed using STATA 12.0 software.

Results: A total of 11 trials involving 2058 patients with NSCLC were included in our study. Significant correlations were observed between HOXA-AS2 and TNM stage (III-IV) (RR=2.173, 95% CI: 1.386-5.437, P< 0.05) and HOTTIP and age (≥60-year-old) (RR=2.628, 95% CI: 1.185-5.829, P< 0.05) and non-smoking (RR=0.387, 95% CI: 0.156-0.959, P< 0.05). The combined results indicated a significant association between HOXA5 and increased overall survival (HR = 0.69, 95% CI = 0.57-0.84, P < .001). Additionally, HOXA-AS2, HOXA11 and HOTTIP were identified as potential independent predictors for poorer OS (HOXA-AS2: HR =3.48, 95% CI = 1.95 to 6.21, P < 0.05; HOXA11: HR=1.39, 95%CI = 1.08 to 1.79, P < 0.05; HOTTIP: HR=2.44, 95%CI = 1.10 to 5.42, P < 0.05). The prognostic significance of HOXA1, HOXA3 and HOXA4 was uncertain (HOXA1: HR=1.40, 95% CI =0.28 to 7.06, P > 0.05; HOXA3: HR=1.20, 95% CI = 0.96 to 1.50, P > 0.05; HOXA4: HR=0.97, 95% CI = 0.77 to 1.23, P > 0.05).

Conclusions: The HOXA gene family has some potential to emerge as a novel prognostic factor for NSCLC and is correlated with some clinicopathological parameters such as the TNM stage, age and smoking. However, further meticulously designed prospective studies are warranted to substantiate these findings.

References

Sang Y, Zhou F, Wang D, Bi X, Liu X, Hao Z . Up-regulation of long non-coding HOTTIP functions as an oncogene by regulating HOXA13 in non-small cell lung cancer. Am J Transl Res. 2016; 8(5):2022-32. PMC: 4891416. View

Sun Y, Hu B, Wang Q, Ye M, Qiu Q, Zhou Y . Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a. Cell Death Dis. 2018; 9(2):85. PMC: 5833383. DOI: 10.1038/s41419-017-0113-5. View

Peng F, Shi X, Meng Y, Dong B, Xu G, Hou T . Long non-coding RNA HOTTIP is upregulated in renal cell carcinoma and regulates cell growth and apoptosis by epigenetically silencing of LATS2. Biomed Pharmacother. 2018; 105:1133-1140. DOI: 10.1016/j.biopha.2018.06.081. View

Zhang S, Wang W, Liu G, Xie S, Li Q, Li Y . Long non-coding RNA HOTTIP promotes hypoxia-induced epithelial-mesenchymal transition of malignant glioma by regulating the miR-101/ZEB1 axis. Biomed Pharmacother. 2017; 95:711-720. DOI: 10.1016/j.biopha.2017.08.133. View

Gan B, He R, Zhang Y, Wei D, Hu X, Chen G . Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis. Int J Oncol. 2018; 53(4):1557-1579. PMC: 6086630. DOI: 10.3892/ijo.2018.4508. View

Loh M, Liem N, Vaithilingam A, Lim P, Sapari N, Elahi E . DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach. BMC Gastroenterol. 2014; 14:55. PMC: 3986689. DOI: 10.1186/1471-230X-14-55. View

Cui T, Lin G, Dai Y, Zheng J, Chen Z, Chen Q . LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2019; 23(3 Suppl):264-273. DOI: 10.26355/eurrev_201908_18656. View

Navarro A, Moises J, Santasusagna S, Marrades R, Vinolas N, Castellano J . Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer. BMC Pulm Med. 2019; 19(1):55. PMC: 6393998. DOI: 10.1186/s12890-019-0816-8. View

Chang C, Chen Y, Hsieh C, Liu Y, Yu S, Chen J . HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer. J Cancer. 2017; 8(6):1071-1081. PMC: 5436261. DOI: 10.7150/jca.17295. View

10.

Sun Y, Zhou Y, Bai Y, Wang Q, Bao J, Luo Y . A long non-coding RNA HOTTIP expression is associated with disease progression and predicts outcome in small cell lung cancer patients. Mol Cancer. 2017; 16(1):162. PMC: 5646126. DOI: 10.1186/s12943-017-0729-1. View

11.

Zhang H, Zhao L, Wang Y, Xi M, Liu S, Luo L . Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma. Tumour Biol. 2015; 36(11):8805-9. DOI: 10.1007/s13277-015-3645-2. View

12.

Kim D, Kim M, Lee J, Lee S, Choi J, Yoon G . Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features. Mol Carcinog. 2009; 48(12):1109-15. DOI: 10.1002/mc.20561. View

13.

Lau J, Ioannidis J, Schmid C . Quantitative synthesis in systematic reviews. Ann Intern Med. 1998; 127(9):820-6. DOI: 10.7326/0003-4819-127-9-199711010-00008. View

14.

Mandeville I, Aubin J, LeBlanc M, Lalancette-Hebert M, Janelle M, Tremblay G . Impact of the loss of Hoxa5 function on lung alveogenesis. Am J Pathol. 2006; 169(4):1312-27. PMC: 1698857. DOI: 10.2353/ajpath.2006.051333. View

15.

Lin C, Wang Y, Zhang S, Yu L, Guo C, Xu H . Transcriptional and posttranscriptional regulation of HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in esophageal squamous carcinoma cells. Oncogene. 2017; 36(38):5392-5406. DOI: 10.1038/onc.2017.133. View

16.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

17.

Kinkead R, LeBlanc M, Gulemetova R, Lalancette-Hebert M, Lemieux M, Mandeville I . Respiratory adaptations to lung morphological defects in adult mice lacking Hoxa5 gene function. Pediatr Res. 2004; 56(4):553-62. DOI: 10.1203/01.PDR.0000139427.26083.3D. View

18.

Abe M, Hamada J, Takahashi O, Takahashi Y, Tada M, Miyamoto M . Disordered expression of HOX genes in human non-small cell lung cancer. Oncol Rep. 2006; 15(4):797-802. View

19.

Yoo K, Park Y, Kim H, Jung W, Chang S . Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma. Pathol Int. 2010; 60(10):661-6. DOI: 10.1111/j.1440-1827.2010.02578.x. View

20.

Zintzaras E, Ioannidis J . HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics. 2005; 21(18):3672-3. DOI: 10.1093/bioinformatics/bti536. View